< Back to companies
MyndBlue

MyndBlue

New York, New York, United States

MyndBlue is a digital MedTech company specializing in major depressive disorder (MDD), post-traumatic stress disorder (PTSD) and artificial intelligence. MyndBlue is developing a personalized and predictive clinical score combining physiological measurements from outpatients, machine learning, and artificial intelligence. MyndBlue's mission is to enable physicians to conduct objective clinical monitoring of their patients during and distance from consultations, intervene earlier through real-time detection of complications, and predict the trajectory of the disease to anticipate crisis and relapse. MyndBlue aims to provide patients with optimal treatment to increase their recovery rate and chances of regaining a high-quality life.

Share
Shareable draft
Get Involved in MyndBlue

Company Info

Founded
2015
Website
myndblue.ai/

Categories

Mental HealthDepressionPTSDAI / ML

Disease Areas

Technologies

Machine LearningPredictive AnalyticsPhysiological Monitoring
Only accessible to MedStartr community members. Join now

What do you think of MyndBlue?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in MyndBlue
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free